Welcome to Infectious Diseases Conferences

Upcoming Infectious Diseases Conferences

Infectious Diseases Conferences 2017

Infectious Diseases Conferences 2018

Conferenceseries Destinations


Target Audience for Infectious Diseases Conferences

With members from around the world focused on learning about global trends on emerging infectious diseases and its advances in therapeutic and diagnostic market, this is your best opportunity to reach the largest assemblage of participants from the Infectious diseases community. These particular stream conferences conduct presentations, distributes information, conducts meetings with current and potential scientists, make a splash with new drug developments, and receive name recognition at these events. World renowned speakers, the most recent therapeutic and diagnostic techniques, developments, and the Novel technologies and therapeutic measures for infectious diseases prevention and control are hallmarks of these conferences.

Targeted Audience

  • Directors, Board Members, Presidents, Vice Presidents, Deans and Head of the Departments

  • Infectious Diseases Researchers, Scientists, Faculties, Students

  • Infectious Diseases Associations and Societies

  • Medical Colleges

  • Pharmaceutical Companies and Industries

  • Medical Devices Manufacturing Companies

  • Drug Manufacturing Companies and Industries

  • Laboratory Technicians and Diagnostic Companies

  • Business Entrepreneurs and Industrialists

  • Training Institutes

  • Software Developing Companies

  • Data Management Companies

Benefits of Attending CME Conferences (5 lines)

1.      They encourage discussions

Live conferences provide doctors with the opportunity to engage in discussions with presenters about educational material, which can help them understand it better.

2.      They provide networking opportunities

 Attending a conference gives doctors a chance to meet other women’s health   professionals from around the U.S.

3.      They introduce new ideas and approaches

Learning from an online program can teach doctors new concepts, but attending a conference in person takes this one step further. 

4.      They offer practical experience

Taking a continuing medical education course online might involve watching videos that show new procedural methods or other demonstrations. 

5.       They explain new or modified regulations

Doctors can find these regulations online, but the information presented can be confusing and difficult to fully understand. 

 

Benefits of Attending CPD/CE Conferences (5 lines)

  • Allows you to fill gaps in your knowledge and skills to become more productive and efficient.
  • Builds confidence and credibility to stand out from the crowd
  • Achieves your career goals
  • Demonstrates professional status

 

Market Value of Infectious Diseases

The global market for infectious disease treatments was valued at $90.4 billion in 2009. This market is expected to increase at a compound annual growth rate (CAGR) of 8.8% to reach $148 billion in 2016. The largest market share belongs to antibiotic treatments for bacterial and fungal diseases at 53% of the total infectious disease treatment market.  Fungal disease treatments will experience a slightly higher compound annual growth rate (CAGR) of 6.2%, from $4.6 billion in 2009 to $6.2 billion in 2014. Viral disease treatments will have the fastest compound annual growth rate (CAGR) of 12.1%, increasing from nearly $45 billion in 2009 to $79 billion in 2016.

      In America

Global IVD infectious disease market is expected to reach 25.9 billion by 2022 according to a new report by Grand View Research Inc. Introduction of technologically advanced diagnostic devices along with associated benefits such as rapid result availability, improved accuracy, ease of usage, and cost-effectiveness is expected to serve this market as high-impact rendering drivers over the forecast period. For instance, Abbott Molecular has introduced a new range of real-time assays for HBV and HCV infections on its m200 platform.

   In Europe
The europe molecular diagnostics market is expected to reach USD4.0 billion by 2024, according to a new report by Grand View Research, Inc. Growing geriatric population and the increasing prevalence of neurological and cardiovascular disorders is expected to drive the growth of molecular diagnostics. Moreover, increasing demand for more efficient healthcare delivery to facilitate early diagnostics is further expected to boost market growth. 

 

In Asia and Middle East
Asia-Pacific is expected to register the highest growth rate during the forecast period, owing to the high prevalence of infectious diseases, and huge investment opportunities due to increase in healthcare expenditure. The growth of the IDD market in Asia-Pacific will revolve around China, India, Australia, and New Zealand. Countries in the Middle East will also show growth.